Edition:
United States
Pictures | Mon Feb 25, 2013 | 9:07am EST

Insight: Cancer drugs proving worth earlier in testing

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer...more

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
1 / 7
Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer...more

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
2 / 7
Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer...more

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
3 / 7
Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer...more

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
4 / 7
Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer...more

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
5 / 7
Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer...more

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
6 / 7
Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer...more

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
7 / 7

Next Slideshows

Reckitt loses U.S. bid to block generic heroin addict drug

LONDON (Reuters) - U.S. regulators approved two generic versions of Reckitt Benckiser's heroin addiction drug and rejected its bid to block rival products on...

Feb 25 2013

J&J sees 4 cent per share Q1 charge for Venezuela devaluation

(Reuters) - Diversified healthcare company Johnson & Johnson, which makes consumer products like the Neutrogena-brand line, said on Monday that Venezuela's...

Feb 25 2013

Germany investigates possible organic egg fraud

BERLIN (Reuters) - German authorities are investigating possible large-scale fraud by organic egg producers amid increased concern over food industry practices...

Feb 25 2013

Hotels take fitness amenities to the great outdoors

NEW YORK (Reuters) - From sightseeing city runs and nature hikes down country trails to surfing sessions, hotels are luring leisure and business clients outside...

Feb 25 2013

MORE IN PICTURES

Today in Sports

Today in Sports

Our top sports photography of the day.

At the epicenter of Mexico's earthquake

At the epicenter of Mexico's earthquake

Picking up the pieces in San Juan Pilcaya and Axochiapan, two towns near the epicenter of last week's devastating earthquake in central Mexico.

St. Croix damage from above

St. Croix damage from above

Aerial photos of the destruction to St. Croix following Hurricane Maria.

Puerto Rico in the dark

Puerto Rico in the dark

Much of the island is still without electricity five days after Maria struck with ferocious winds and torrential rains.

Athletes protest racial injustice

Athletes protest racial injustice

Athletes stage on-field protests against police brutality and racial injustice, as President Donald Trump called for owners to fire those who refuse to stand during the anthem.

Rio de Janeiro's drug war

Rio de Janeiro's drug war

Hundreds of Brazilian soldiers pour into Rio de Janeiro's Rocinha slum in a bid to help quell drug-related violence.

Best of Invictus Games

Best of Invictus Games

Highlights from the Invictus Games in Toronto, where more than 550 injured and wounded servicemen and women from 17 allied nations take part in 12 adaptive sports.

Cleaning up in the Florida Keys

Cleaning up in the Florida Keys

Residents survey the damage after Hurricane Irma blasts the Florida Keys.

Meet Team USA

Meet Team USA

Portraits of the athletes who will represent the United States at the 2018 Winter Olympics in Pyeongchang, South Korea.

Trending Collections

Pictures

Podcast